Ewing sarcoma genomics and recent therapeutic advancements
Ewing sarcomas are highly heterogenous mesenchymal tumors that develop in bone or soft tissue and primarily affect children, teenagers, and young adults. After osteosarcoma, it is the second most common malignant bone sarcoma.
Manisha Chavan +6 more
doaj +2 more sources
Advances in molecular pathology of Ewing sarcoma [PDF]
Ewing sarcoma is a rare malignant small round cell mesenchymal neoplasm with a characteristic FET family-ETS family fusion gene, and is classified as undifferentiated small round cell sarcoma in the fifth revision of the WHO Classification of Tumors of ...
LIU Hengan, WANG Chaofu
doaj +3 more sources
Extraosseous Ewing sarcoma of the pancreas: a case report [PDF]
Extraosseous Ewing sarcoma is a rare and aggressive malignancy belonging to the Ewing sarcoma family of tumors, primarily affecting soft tissues such as the pelvis, retroperitoneum, and chest wall.
Neslihan Nisa Gecici +3 more
doaj +2 more sources
Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma [PDF]
Ewing sarcoma tumors are defined by chromosomal translocations fusing EWSR1 to ETS family genes, most commonly FLI1. The resulting EWS::FLI1 fusion oncoprotein drives tumorigenesis while simultaneously generating unique metabolic and molecular ...
Mian T. Mhindu +4 more
doaj +2 more sources
Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma
We report a response to pazopanib in a 69-year-old man with heavily pre-treated metastatic extraosseous Ewing sarcoma in addition to molecular profiling of his tumor.
Steven Attia +12 more
doaj +2 more sources
Cutaneous Ewing Sarcoma and Ewing Sarcoma of the Bone: Distinct Diseases [PDF]
Ewing sarcoma is an aggressive mesenchymal malignancy. It is the second most common bone tumor among children and adolescents and less commonly presents as a soft tissue or primary skin lesion.
Montreh Tavakkoli, Lisa Mueller
doaj +2 more sources
Characteristics of human Ewing/PNET sarcoma models
Ewing/PNET (peripheral neuroepithelioma) tumors are rare aggressive bone sarcomas occurring in young people. Rare-disease clinical trials can require global collaborations and many years. In vivo models that as accurately as possible reflect the clinical
Teicher Beverly +5 more
doaj +1 more source
Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma [PDF]
Ewing sarcoma is a highly aggressive solid malignancy affecting children and young adults. Ewing sarcoma is driven primarily by EWSR1::FLI1, a fusion oncoprotein that has been notoriously difficult to target with traditional pharmacologic agents.
Helen F. Gloege +17 more
doaj +2 more sources
Primary Ewing sarcoma of the pancreas: A rare extraosseous presentation [PDF]
Ewing sarcoma is an aggressive neoplasm that is common among children and adolescents, most frequently affecting the pelvis and long bones. Although rare, Ewing sarcoma is known to also occur in extraosseous locations, affecting a broad range of soft ...
Elias Lugo-Fagundo, BS +3 more
doaj +2 more sources
Bridged bicyclic carboxylic acids for treating osteosarcoma and Ewing sarcoma [PDF]
The present invention provides a composition for use in a method of treating osteosarcoma, Ewing sarcoma and/or a metastatic cancer originating from osteosarcoma or Ewing sarcoma. The present invention also provides a method of treating a cancer selected
Fraser, William, Green, Darrell
core +3 more sources

